Global Covid-19 Serology Testing Market Growth (Status and Outlook) 2023-2029

Global Covid-19 Serology Testing Market Growth (Status and Outlook) 2023-2029

Serology tests are blood-based tests that can be used to identify whether people have been exposed to a particular pathogen by looking at their immune response.These tests can give greater detail into the prevalence of a disease in a population by identifying individuals who have developed antibodies to the virus.
LPI (LP Information)' newest research report, the “Covid-19 Serology Testing Industry Forecast” looks at past sales and reviews total world Covid-19 Serology Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Covid-19 Serology Testing sales for 2023 through 2029. With Covid-19 Serology Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Covid-19 Serology Testing industry.
This Insight Report provides a comprehensive analysis of the global Covid-19 Serology Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Covid-19 Serology Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Covid-19 Serology Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Covid-19 Serology Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Covid-19 Serology Testing.
The global Covid-19 Serology Testing market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
North America is the largest consumption place, with a consumption market share nearly 35.21% in 2020. APAC is the second largest consumption place with the consumption market share of 32.43%.
Market competition is intense. Abbott, Guangzhou Wondfo Biotech, BioMedomics, Kantaro, Roche, etc. are the leaders of the industry. The top 5 companies occupied about half of the market in 2019.
Among the classification of Covid-19 Serology Testing, the proportion of Chemiluminescent Immunoassay in 2020 is about 73.45%.
Covid-19 Serology Testing is widely used for Hospitals and Third-party laboratory. The most proportion of Covid-19 Serology Testing is Hospitals, and the proportion in 2020 is 52.47%.
This report presents a comprehensive overview, market shares, and growth opportunities of Covid-19 Serology Testing market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Rapid Diagnostic Test (RDT)
Chemiluminescent Immunoassay
Other
Segmentation by application
Hospitals
Third-party laboratory
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Guangzhou Wondfo Biotech
BioMedomics
Kantaro
Roche
Cellex
Innovita Biological Technology
Zhejiang Orient Gene Biotech
Ortho Clinical Diagnostics
Guangdong Hecin-Scientific
Dynamiker Biotechnology (Tianjin)
Chembio Diagnostics
Safecare Bio-Tech

Please note: The report will take approximately 2 business days to prepare and deliver.